Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.

Who May Be Eligible (Plain English)

Who May Qualify: - Ischemic stroke or transient ischemic attack (ABCD2 score ≥3) - Age ≥40 years - Pre-existing or newly diagnosed hypertension - willing to sign a consent form from the patient or legal representative Who Should NOT Join This Trial: - Known high-risk source of cardioembolism - Known indication for anticoagulation - Contraindication for anticoagulation - Pacemaker - Non-compliance to study interventions as judged by the investigator - Serious condition hampering the study conduct Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Ischemic stroke or transient ischemic attack (ABCD2 score ≥3) * Age ≥40 years * Pre-existing or newly diagnosed hypertension * Informed consent from the patient or legal representative Exclusion Criteria: * Known high-risk source of cardioembolism * Known indication for anticoagulation * Contraindication for anticoagulation * Pacemaker * Non-compliance to study interventions as judged by the investigator * Serious condition hampering the study conduct

Treatments Being Tested

DIAGNOSTIC_TEST

ECG monitoring for 3 weeks

A 3-week continuous ECG monitoring to detect occult AF.

OTHER

Self-monitoring of BP and self-titration of antihypertensive medication

One-week monthly self-monitoring of BP and self-titration of antihypertensive medication according to a pre-specified protocol, assisted with a mobile device application.

Locations (4)

Kanta-Häme Central Hospital
Hämeenlinna, Finland
Helsinki University Hospital
Helsinki, Finland
Hyvinkää Hospital
Hyvinkää, Finland
Päijät-Häme Central Hospital
Lahti, Finland